Antibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12363-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CCNDBP1 antibody
- Antibody type
- Polyclonal
- Description
- CCNDBP1 antibody (Cat. #12363-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition.
UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway.
Ubiquitin-specific protease 22 enhances intestinal cell proliferation and tissue regeneration after intestinal ischemia reperfusion injury.
Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo.
Lithium chloride inhibits cell survival, overcomes drug resistance, and triggers apoptosis in multiple myeloma via activation of the Wnt/β-catenin pathway.
HOXA5 is a tumor suppressor gene that is decreased in gastric cancer.
Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.
Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARγ.
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.
LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.
Yang L, Wu Z, Sun W, Luo P, Chen S, Chen Y, Yan W, Li Y, Wang C
Frontiers in oncology 2021;11:687012
Frontiers in oncology 2021;11:687012
UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway.
Ye Y, Huang S, Wu Y
Cancer management and research 2019;11:2339-2348
Cancer management and research 2019;11:2339-2348
Ubiquitin-specific protease 22 enhances intestinal cell proliferation and tissue regeneration after intestinal ischemia reperfusion injury.
Ji AL, Li T, Zu G, Feng DC, Li Y, Wang GZ, Yao JH, Tian XF
World journal of gastroenterology 2019 Feb 21;25(7):824-836
World journal of gastroenterology 2019 Feb 21;25(7):824-836
Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo.
Wang Y, Meng Y, Zhang S, Wu H, Yang D, Nie C, Hu Q
OncoTargets and therapy 2018;11:6039-6048
OncoTargets and therapy 2018;11:6039-6048
Lithium chloride inhibits cell survival, overcomes drug resistance, and triggers apoptosis in multiple myeloma via activation of the Wnt/β-catenin pathway.
Yao R, Sun X, Xie Y, Liu L, Han D, Yao Y, Li H, Li Z, Xu K
American journal of translational research 2018;10(8):2610-2618
American journal of translational research 2018;10(8):2610-2618
HOXA5 is a tumor suppressor gene that is decreased in gastric cancer.
Peng X, Zha L, Chen A, Wang Z
Oncology reports 2018 Sep;40(3):1317-1329
Oncology reports 2018 Sep;40(3):1317-1329
Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Song H, Dong M, Zhou J, Sheng W, Li X, Gao W
Oncology reports 2018 Mar;39(3):1432-1440
Oncology reports 2018 Mar;39(3):1432-1440
Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.
Wang AL, Li Y, Zhao Q, Fan LQ
Molecular medicine reports 2018 Jun;17(6):7721-7729
Molecular medicine reports 2018 Jun;17(6):7721-7729
Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARγ.
Zhang JR, Lu QB, Feng WB, Wang HP, Tang ZH, Cheng H, Du Q, Wang YB, Li KX, Sun HJ
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Jun;102:711-717
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Jun;102:711-717
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.
Chen YA, Tzeng DTW, Huang YP, Lin CJ, Lo UG, Wu CL, Lin H, Hsieh JT, Tang CH, Lai CH
Cancers 2018 Dec 31;11(1)
Cancers 2018 Dec 31;11(1)
LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.
Liu Y, Wang LL, Chen S, Zong ZH, Guan X, Zhao Y
Journal of cellular and molecular medicine 2018 Aug;22(8):3955-3964
Journal of cellular and molecular medicine 2018 Aug;22(8):3955-3964
No comments: Submit comment
No validations: Submit validation data